Oleolive, the makers of Oligen, is not a supplement or marketing company, we are a biotech company doing cutting edge research on serious diseases. We develop therapeutics for neurodegenerative diseases and rare cancers. We took this insanely high standard and applied it to the development of Oligen. Oligen has been thoroughly researched in a wide array of models from in vitro to in vivo and even clinically as oleocanthal. There are hundreds of peer reviewed and published papers on the benefits of oleocanthal consumption and we are continually looking to improve the field. Our motto since inception has been "Science First" and we stuck to it, taking four years to fully develop and commercialize our product, now known as Oligen. 

As we developed Oligen, we kept a few things in mind that were important to us as a company and important to our customers. With a commitment to simplicity, Oligen boasts a carefully curated blend of four key ingredients. Firstly, our active component is a patented extract of extra virgin olive oil, produced in-house with water as the primary solvent, ensuring the delivery of the natural compound in its purest form. Complementing this is FujiCalin, our exclusive excipient—a calcium-based product at its core. In addition, there are trace amounts of PEG600, serving as an antioxidant and aiding in the distribution of active ingredients within the calcium powder, along with magnesium stearate to facilitate smooth product flow during capsule filling.

This thoughtfully composed formulation represents our dedication to providing you, our valued customer, with a product where every ingredient serves a purpose. Oligen embodies this ethos with minimal packaging, a clinical layout, and simple instructions—just two capsules per day with a meal to experience Oligen's benefits.